Microhaematuria as a diagnostic marker of Schistosoma haematobium in an outpatient clinical setting: results from a cross-sectional study in rural Ghana

The utility of microhaematuria (as measured by urine reagent strips) as a surrogate marker for Schistosoma haematobium infection is not established in patients with urogenital symptoms presenting to clinical settings, although previous studies have demonstrated its utility in screening asymptomatic individuals in large community or school-based settings. In this cross-sectional study of 201 patients, multivariate analysis demonstrated microhaematuria as an independent predictor of S. haematobium infection (OR, 4.29; 95% CI, 1.6–11.9) in individuals presenting with urogenital symptoms to an outpatient medical department (OPD) at a rural Ghanaian medical center. Microhaematuria is predictive of S. haematobium infections in clinical settings in endemic regions.